misonidazole has been researched along with Carcinoma, Renal Cell in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chatellier, G; Cuenod, CA; Faraggi, M; Fournier, L; Hindié, E; Huchet, V; Hugonnet, F; Itti, E; Medioni, J; Oudard, S; Smadja, C | 1 |
| Chowdhury, NF; Kuge, Y; Murakami, M; Nishijima, K; Takiguchi, M; Tamaki, N; Yu, W; Zhao, S; Zhao, Y | 1 |
| Bolton, DM; Davis, ID; Foo, SS; Lawrentschuk, N; Murone, C; Poon, AM; Putra, LG; Scott, AM | 1 |
| Elson, P; Glover, D; Kvols, L; Trump, D; Vogl, S | 1 |
1 trial(s) available for misonidazole and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Metastatic renal cell carcinoma: relationship between initial metastasis hypoxia, change after 1 month's sunitinib, and therapeutic response: an 18F-fluoromisonidazole PET/CT study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Renal Cell; Cell Hypoxia; Cohort Studies; Disease Progression; Humans; Indoles; Kidney Neoplasms; Middle Aged; Misonidazole; Neoplasm Metastasis; Positron-Emission Tomography; Prognosis; Pyrroles; Sunitinib; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult | 2011 |
3 other study(ies) available for misonidazole and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and 18F-fluoromisonidazole hypoxia imaging in renal cell carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Humans; Hypoxia; Kidney Neoplasms; Mice; Mice, Nude; Misonidazole; Niacinamide; Phenylurea Compounds; Platelet Endothelial Cell Adhesion Molecule-1; Radiopharmaceuticals; Sorafenib; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2012 |
Assessing regional hypoxia in human renal tumours using 18F-fluoromisonidazole positron emission tomography.
Topics: Adult; Aged; Carcinoma, Renal Cell; Female; Humans; Hypoxia; Immunohistochemistry; Kidney Neoplasms; Male; Middle Aged; Misonidazole; Neovascularization, Pathologic; Nephrectomy; Oxygen; Polarography; Positron-Emission Tomography; Radiopharmaceuticals | 2005 |
Phase II trial of misonidazole (MISO) and cyclophosphamide (CYC) in metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Cyclophosphamide; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Humans; Kidney Neoplasms; Misonidazole | 1986 |